Anon,
Yes. I routinely withdraw the IND (312.38) after all subject interaction is complete, site PIs have signed-off on the eCRFs and the database is locked, all study drug is destroyed/accounted for, and the sites have closed-out with their reviewing IRB (all research activities are finished at the site).
Our "main" IRB stays open while we analyze data and write publications (this may be an academia thing).
David
------------------------------
David Jensen PhD, RAC
Regulatory Affairs Scientist
Durham NC
United States
------------------------------
Original Message:
Sent: 22-Feb-2022 14:13
From: Anonymous Member
Subject: Terminating an IND
This message was posted by a user wishing to remain anonymous
Can an IND be closed with the FDA after all participants are off study but the study will remain open for data analysis with the IRB?